News
At the current average wholesale cost of the smaller, commercially available alteplase vial (containing 50 mg), the average cost per milligram of alteplase is $27.50.
Alteplase was prepared (1) at a concentration of 1 mg/ mL and stored as a 1-mL portion in a polypropylene tube at -20°C for six months or (2) as a 2-mL portion in glass borosilicate vials at -70 ...
The study compared IV tenecteplase to alteplase in almost 1,600 individuals with acute ischemic stroke recruited across 22 Canadian stroke centers, with results showing 0.25 mg/kg tenecteplase was ...
Boehringer Ingelheim (BI) is celebrating after an independent evaluation in the UK has reconfirmed that the benefits of its clot-busting drug alteplase outweigh the risks for acute ischaemic stroke.
Alteplase Medication Information. Discover comprehensive details about Alteplase, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or ...
4mon
GlobalData on MSNGenentech wins FDA approval for second stroke treatment - MSNGenentech said it will also introduce a new 25mg vial configuration in the coming months to support the approval of TNKase ..
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late ...
SOUTH SAN FRANCISCO, Calif., March 03, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Alteplase(Cathflo Activase) generic is an enzyme (tissue plasminogen activator (tPA)), prescribed for heart attack, stroke, and pulmonary embolism. It helps to break down unwanted blood clots.
For the new study, researchers compared nearly 9,500 patients who received tenectplase for stroke to more than 70,000 who got alteplase between July 2020 and June 2022.
At 90 days, the proportion of patients with a modified Rankin Scale (mRS) score of 0 to 1, the primary outcome, was 62% in the tenecteplase group and 58% in the alteplase group (RR 1.07; 95% CI 0.98-1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results